Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02614469Phase 1Completed
Phase 1, randomised, open-label trial of inosine in Parkinson's disease (PD) (2 arms). Primary endpoints: Maximum Observed Serum Urate Concentration, Area Under the Serum Concentration-time Curve From Time 0 to Time t and 4 more. Started Mar 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02614469.